Clinical Trial Update: Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial results evaluating the efficacy and tolerability of NM-BL in patients with exocrine pancreatic insufficiency due to cystic fibrosis; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• NM-BL

Snippet

Sponsor: Nordmark Arzneimittel GmbH & Co. KG | Conditions: Pancreatic Insufficiency, Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED